Trademark: 88118686
Word
DIGITOME
Status
Registered
Status Code
700
Status Date
Tuesday, March 17, 2020
Serial Number
88118686
Registration Number
6010838
Registration Date
Tuesday, March 17, 2020
Mark Type
4000
Filing Date
Saturday, September 15, 2018
Published for Opposition
Tuesday, December 31, 2019

Trademark Owner History
Medable, Inc. - Original Registrant

Classifications
44 Health care services, namely, providing a database in the field of disease detection and management information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Health care services, namely, providing a database in the field of disease therapy information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; Remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes
42 Software as a service (SAAS) services, namely, hosting software for use by others for use for disease progression prediction; Software as a service (SAAS) services, namely, hosting software for use by others for use for medical status assessment; Software as a service (SAAS) services, namely, hosting software for use by others for use for overall health assessment; Software as a service (SAAS) services, namely, hosting software for use by others for use to determine effective therapies and medications; Software as a service (SAAS) services, namely, hosting software for use by others for use to make medical decisions; Application service provider (ASP) featuring software for use in the collection, processing, storage and exchange of human health and disease data; Application service provider (ASP) featuring software for use in the collection, processing, storage and exchange of genetic data; Application service provider (ASP) featuring software for use to derive insights and or understanding about human health and disease.; Application service provider (ASP) featuring software for use for predictive analytics; Application service provider (ASP) featuring software for use for disease progression prediction; Application service provider (ASP) featuring software for use for medical status assessment; Application service provider (ASP) featuring software for use for overall health assessment; Application service provider (ASP) featuring software for use to determine effective therapies and medications; Application service provider (ASP) featuring software for use to make medical decisions; Application service provider (ASP) featuring software for use to assist in overall medical and therapeutic decision making; Conducting clinical trials for others; Conducting research and clinical trials for others relating to medical devices and pharmaceuticals in the field of ophthalmology; Medical and scientific research, namely, conducting clinical trials for others; Platform as a service (PAAS) featuring computer software platforms for in the collection, processing, storage and exchange of human health and disease data; Platform as a service (PAAS) featuring computer software platforms for in the collection, processing, storage and exchange of genetic data; Platform as a service (PAAS) featuring computer software platforms for to derive insights and or understanding about human health and disease.; Platform as a service (PAAS) featuring computer software platforms for for predictive analytics; Platform as a service (PAAS) featuring computer software platforms for for disease progression prediction; Platform as a service (PAAS) featuring computer software platforms for for medical status assessment; Platform as a service (PAAS) featuring computer software platforms for for overall health assessment; Platform as a service (PAAS) featuring computer software platforms for to determine effective therapies and medications; Platform as a service (PAAS) featuring computer software platforms for to make medical decisions; Providing medical and scientific research information in the field of clinical trials; Providing medical and scientific research information in the field of pharmaceuticals and clinical trials

Trademark Events
Feb 23, 2022
Teas Change Of Correspondence Received
Feb 23, 2022
Attorney/Dom.Rep.Revoked And/Or Appointed
Feb 23, 2022
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Mar 17, 2020
Registered-Principal Register
Dec 31, 2019
Official Gazette Publication Confirmation E-Mailed
Dec 31, 2019
Published For Opposition
Dec 11, 2019
Notification Of Notice Of Publication E-Mailed
Dec 4, 2019
Attorney/Dom.Rep.Revoked And/Or Appointed
Dec 4, 2019
Teas Revoke/App/Change Addr Of Atty/Dom Rep Received
Nov 26, 2019
Approved For Pub - Principal Register
Nov 26, 2019
Examiner's Amendment Entered
Nov 26, 2019
Notification Of Examiners Amendment E-Mailed
Nov 26, 2019
Examiners Amendment E-Mailed
Nov 26, 2019
Examiners Amendment -Written
Oct 6, 2019
Notification Of Non-Final Action E-Mailed
Oct 6, 2019
Non-Final Action E-Mailed
Oct 6, 2019
Non-Final Action Written
Sep 30, 2019
Notice Of Revival - E-Mailed
Sep 30, 2019
Petition To Revive-Granted
Sep 30, 2019
Teas Petition To Revive Received
Jul 30, 2019
Abandonment Notice E-Mailed - Failure To Respond
Jul 30, 2019
Abandonment - Failure To Respond Or Late Response
Jan 1, 2019
Notification Of Non-Final Action E-Mailed
Jan 1, 2019
Non-Final Action E-Mailed
Jan 1, 2019
Non-Final Action Written
Dec 27, 2018
Assigned To Examiner
Sep 22, 2018
New Application Office Supplied Data Entered In Tram
Sep 19, 2018
New Application Entered In Tram

Trademark Alertz updated from USPTO on 2030-01-24